Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank56
3Y CAGR+15.1%
5Y CAGR-16.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+15.1%/yr
vs +15.1%/yr prior
5Y CAGR
-16.3%/yr
Recent acceleration
Acceleration
-0.0pp
Decelerating
Percentile
P56
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.58 | +197.3% |
| 2024 | -3.68 | -121.9% |
| 2023 | 16.79 | +615.6% |
| 2022 | 2.35 | -69.1% |
| 2021 | 7.60 | -12.9% |
| 2020 | 8.72 | +43.3% |
| 2019 | 6.09 | +355.4% |
| 2018 | 1.34 | +102.1% |
| 2017 | -63.87 | +62.2% |
| 2016 | -168.80 | - |